Evidence map›Paper›PMID 23383130›Full record

ArticlePloS one2013

Germline allele-specific expression of DAPK1 in chronic lymphocytic leukemia.

Quan-Xiang Wei, Rainer Claus, Thomas Hielscher, Daniel Mertens, Aparna Raval, Christopher C Oakes, Stephan M Tanner, Albert de la Chapelle, John C Byrd, Stephan Stilgenbauer and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Quan-Xiang WeiDivision of Epigenomics and Cancer Risk Factors, German Cancer Research Center, Heidelberg, Germany.
Rainer Claus
Thomas Hielscher
Daniel Mertens
Aparna Raval
Christopher C Oakes
Stephan M Tanner
Albert de la Chapelle
John C Byrd
Stephan Stilgenbauer
Christoph Plass
Heidelberg University · DEEpigenomics (Germany) · DEThe Ohio State University · USCancer Genetics (United States) · USStanford University · USUniversität Ulm · DE

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
Tissue CoreP01CA081534 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI KIPPS, THOMAS J · 2000 to 2016
$59.5M
PathologyP01CA101956 · NCI · OHIO STATE UNIVERSITY · PI BYRD, JOHN C. · 2006 to 2010
$11.4M
SPORE Leukemia Tissue BankP50CA140158 · NCI · OHIO STATE UNIVERSITY · PI BLOOMFIELD, CLARA D · 2009 to 2013
$11.2M
NCI NIH HHS P01 CA081534NCI NIH HHS P01 CA101956NCI NIH HHS P30 CA016058NCI NIH HHS P30 CA016058-35NCI NIH HHS P50 CA140158
6 · The paper itself

Abstract

We previously reported a rare germline variant (c.1-6531) that resulted in allele-specific expression (ASE) of death-associated protein kinase 1 (DAPK1) and predisposition to chronic lymphocytic leukemia (CLL). We investigated a cohort of CLL patients lacking this mutation for the presence of ASE of DAPK1. We developed a novel strategy that combines single-nucleotide primer extension (SNuPE) with MALDI-TOF mass spectrometry, and detected germline DAPK1 ASE in 17 out of 120 (14.2%) CLL patients associated with a trend towards younger age at diagnosis. ASE was absent in 63 healthy controls. Germline cells of CLL patients with ASE showed increased levels of DNA methylation in the promoter region, however, neither genetic nor further epigenetic aberrations could be identified in the DAPK1 5' upstream regulatory region, within distinct exons or in the 3'-UTR. We identified B-lymphoid malignancy related cell line models harboring allelic imbalance and found that allele-specific methylation in DAPK1 is associated with ASE. Our data indicate that ASE at the DAPK1 gene locus is a recurrent event, mediated by epigenetic mechanisms and potentially predisposing to CLL.

Indexed as

AllelesDNA MethylationAge FactorsApoptosis Regulatory ProteinsBase SequenceCalcium-Calmodulin-Dependent Protein KinasesCohort StudiesDeath-Associated Protein KinasesDNA PrimersGermanyGerm-Line MutationHigh-Throughput Screening AssaysHumansLeukemia, Lymphocytic, Chronic, B-CellMolecular Sequence DataReal-Time Polymerase Chain ReactionApoptosis Regulatory ProteinsCalcium-Calmodulin-Dependent Protein KinasesDAPK1 protein, humanDeath-Associated Protein KinasesDNA Primers

Identifiers

PMID23383130
PMCPMC3557246
OpenAlexW2049328902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.